Back to UBS Group AG UBS Group AG

AGNAGN
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in ALLERGAN PLC

As of its Q1 2020 13F, Ubs held 6,853,356 shares of AGN (Allergan), worth $1.2B. Ubs' 13F filings listed AGN from Q1 2019 to Q1 2020, 5 quarterly filings. AGN was 0.6% of Ubs' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$239.2M

Total Shares Change

-1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q1
Increased
6.9M
+6.7%
$1.2B0.6%—
48
2019-Q4
Increased
6.4M
+13.3%
$1.2B0.4%—
43
2019-Q3
Decreased
5.7M
-20.6%
$953.9M0.4%—
0
2019-Q2
Increased
7.1M
+337.1%
$1.2B0.5%—
62
2019-Q1
First report
1.6M
-
$239.2M0.1%—
0

Other major holders of AGN: STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used